Nolimit City · Educational guide
Infectious 5 xWays®
Infectious 5 xWays is a 2021 video slot that pairs xWays® with Infectious xWays®. Nolimit City publishes a 96.02% RTP, a volatility index of 24.78 and a 55,555x max win, with bets from 0.2 to 50.
- RTP
- 96.02%
- Volatility
- Index 24.78
- Max win
- 55,555x
Free demo
Play the demo
The official demo published by Nolimit City. It runs on play money only; no real funds are involved.
If the demo does not appear, check your browser's frame-blocking settings. Screenshot requires granting screen-share permission.
What this guide explains
Key concepts to understand
Format: Video slot · xWays® · Infectious xWays®
Published RTP 96.02%, hit frequency 31.34%
Volatility is the studio's own index (24.78), not a Low/High grade
Offers a feature buy-in — a priced shortcut to the bonus round, not better odds
Slot information
Theme & game design
One-line verdictThe yellow-orange flame outline cuts so cleanly against the navy that the silhouette holds up even as a tiny tile.
Infectious 5 xWays is a 2021 video slot that pairs xWays® with Infectious xWays®. Nolimit City publishes a 96.02% RTP, a volatility index of 24.78 and a 55,555x max win, with bets from 0.2 to 50.
A short story from the game world
A shirtless man with a burning head of hair screams at the viewer, welding goggles pushed up on his brow and a strap of metal gear across his chest. The flames spill over his shoulders against a flat navy background, so he seems to be the only thing in the room giving off heat.
- Built as a ways to win game. 420 titles here share this format, so it is a well-covered one to learn from.
- Its published RTP of 96.02% sits 0.18 points below the 96.2% median of the other 384 ways to win games here. RTP is a long-run theoretical figure, not a per-session one.
- The stated win cap is 55,555×, among the highest in the range for this family (median 9,648×). A cap is a rulebook limit, not an expected outcome.
- A studio-published play-money demo is embedded above, as it is for 141 other Nolimit City titles here.
Nolimit City does not publish volatility for this title, so that field is left empty rather than estimated.
Assembled from the published figures above and arithmetic over the catalogue. It does not forecast results.- You like reading a studio on its own terms — volatility is published as Index 24.78, an index on this studio's own scale rather than a grade, so compare it only with the same studio's titles.
- You want to understand ways-to-win — matches count on adjacent reels wherever they land, so the grid is read by route, not by line.
- You are curious about top-heavy designs — the published ceiling is 55,555x. It is a rulebook limit, not an expectation.
- You want to try before reading further — the studio's own demo runs on this page with play money only.
RTP, volatility, maximum win and bet ranges are reference values and can differ by game version or market.
- Nolimit City has 142 slots in this catalogue; this guide is one of them.
- Among the 142 Nolimit City slots with a single published RTP, 96.02% ranks #122.
- Its published win cap of 55,555× ranks #21 of 142 Nolimit City slots that publish one.
FAQ
Infectious 5 xWays® — frequently asked questions
- What is the RTP of Infectious 5 xWays®?
- The studio-published RTP is 96.02%. RTP is a long-run theoretical return, not a per-session result, and some operators run lower-RTP builds.
- How volatile is Infectious 5 xWays®?
- The studio lists its volatility as Index 24.78. Volatility describes how results are spread, not how likely a win is.
- What is the maximum win on Infectious 5 xWays®?
- The published win cap is 55,555× the stake. A cap is a rule on the paytable, not a likelihood.
- Can I play Infectious 5 xWays® for free?
- Yes. The studio's official demo runs on this page with play money only — no sign-up and no real funds.
- When was Infectious 5 xWays® released?
- Nolimit City lists the release date as 2021-06-01.
Structure match
Closest by published structure
Nearest by format family, volatility, RTP, win cap and theme — computed from published specifications only. A study aid, not a recommendation.
